MarketsStocksVENUSREM
VE

Venus Remedies Ltd

NSE: VENUSREMBSE: 526953Healthcare
Download Research Report7-page PDF
1,646.00
+0.77%
NSE · auto-updates while market open
Prev Close
₹430.00
Day High
₹1,715.10
Day Low
₹1,566.80
Mkt Cap
₹2,352 Cr
P / E
22.9
P / B
3.5
ROE
16.8%
52W High
₹1,633.50
52W Low
₹415.40
Key Metrics
Market Cap
₹2,352 Cr
P / E
22.89
P / B
3.55
EV / EBITDA
14.63
ROCE
12.8%
ROE
16.8%
Debt / Equity
0.00
Book Value
₹496.45
EPS
₹76.89
Div Yield
0.0%
Face Value
₹10
Promoter Holding
41.8%
Revenue · ₹ Cr
341
FY20
548
FY21
599
FY22
556
FY23
601
FY24
648
FY25
770
FY26
Net Profit · ₹ Cr
62
41
27
28
45
103
-10
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹50.0
₹30.9
₹19.9
₹21.3
₹33.9
₹76.9
₹-8.1
FY20FY21FY22FY23FY24FY25FY26
P / E Ratio · price ÷ TTM EPS
08162488410-6Jun 21Feb 23Oct 24Jun 26
P/E 22.0×Median 11.4×TTM EPS
Q1 2026 snapshot
Sales
₹264 Cr
Operating profit
-
OPM
-
Net profit
₹47 Cr
EPS
₹35.53
Scorecard · 7 axes
Quality
Strong
84/100
Valuation
Good
22.9×
Growth
Good
+16.3%
Profitability
Avg
14.8%
Performance
Strong
+275.0%
Entry Point
Bad
101%
Red Flags
Strong
0 flags
Shareholding Pattern
41.8%Promoter
Promoter41.8%
FII2.8%
DII1.2%
Public54.2%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue176.86201.73140.59194.46182.78264.35
Net Profit19.6219.620.1325.5847.49
NPM %11.1%10.4%6.8%10.4%14.0%18.0%
AlertPre-trade